Race Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.5%.

Top 23 shareholders own 33.64% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.1%	Daniel Tillett	17,267,615	US$18.7m	0%	no data
4.21%	Phillip Perry	7,169,078	US$7.7m	5%	no data
4.02%	John Cullity	6,855,700	US$7.4m	-32.1%	no data
3.43%	Mark Juan	5,839,062	US$6.3m	3.11%	no data
2.61%	Merchant Funds Management Pty Ltd	4,450,468	US$4.8m	0%	36.96%
1.08%	Marinella Messina	1,845,245	US$2.0m	5%	no data
0.95%	Sandor Helby	1,625,000	US$1.8m	14.8%	no data
0.88%	Kudoss Investments Pty Ltd	1,500,000	US$1.6m	20%	no data
0.8%	Anthony Robinson	1,370,262	US$1.5m	-6.29%	no data
0.64%	Alan Sauran	1,094,368	US$1.2m	6.12%	no data
0.56%	Brian Walker	955,000	US$1.0m	16.5%	no data
0.56%	Pierpont Investments Pty Ltd	950,000	US$1.0m	0%	no data
0.55%	Surpion Pty Ltd	935,000	US$1.0m	20.7%	no data
0.49%	Tetyana Perry	834,750	US$902.2k	5%	no data
0.49%	Quy Do Van	829,409	US$896.4k	0.44%	no data
0.46%	Kimberley Gartrell	787,500	US$851.1k	5%	no data
0.46%	Jennifer Gartrell	787,500	US$851.1k	5%	no data
0.32%	Kenneth Ridley	540,000	US$583.6k	0%	no data
0.32%	Catherine Ridley	540,000	US$583.6k	0%	no data
0.26%	Phillip Lynch	450,606	US$487.0k	0%	no data
0.2%	Graeme Pocknall	337,256	US$364.5k	0%	no data
0.2%	Vivienne Pocknall	337,255	US$364.5k	0%	no data
0.014%	Mary Harney	24,570	US$26.6k	0%	no data